Journals / The European Research Journal / 2026 / Volume: 11 Issue: 2

Comorbidity results of an obesity center

Müjgan Tuna(Depatment of Family Medicine, Yapı Kredi Health Service, İstanbul, Türkiye)0000-0001-8603-9333
Şenay Kırlak(Diabetes Policlinic Nurse, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Türkiye)0009-0003-7931-7392
Seydahmet Akın(Department of Internal Medicine, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Türkiye)0000-0002-2557-3812
Özlem Çakır Madenci(Department of Biochemistry, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Türkiye)0000-0001-9343-0234
Pages
—
Publication Date
2025-03-04
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, metabolic parameters such as insulin, HOMA-IR, and urea were elevated in females, while HDL and platelet levels were lower in males.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Obesity is linked to numerous severe health conditions, including type 2 diabetes mellitus, heart disease, hypertension, and stroke.
📊
Key Findings & Data:Methods: This prospective study enrolled 393 obese patients (52 male, 341 female) from an outpatient clinic.
💡
Conclusion & Impact:Additionally, metabolic parameters such as insulin, HOMA-IR, and urea were elevated in females, while HDL and platelet levels were lower in males.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Obesity · insulin resistance · metabolic parameters

Abstract

Objectives: Obesity is linked to numerous severe health conditions, including type 2 diabetes mellitus, heart disease, hypertension, and stroke. This study aimed to compare metabolic parameters and anthropometric measurements between male and female patients with obesity to identify gender-based differences in obesity-related health markers. Methods: This prospective study enrolled 393 obese patients (52 male, 341 female) from an outpatient clinic. After an overnight fast (8-10 hours), blood samples were collected to assess a range of parameters: complete blood count, fasting blood glucose, insulin, Hemoglobin A1c (HbA1c), Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Thyroid-stimulating hormone (TSH), total cholesterol, triglycerides, Low-density lipoprotein (LDL), High-density lipoprotein (HDL), 25-hydroxy vitamin D3 (25OHD3), ferritin, iron, and vitamin B12. Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and Body Mass Index (BMI) were calculated, while soft lean mass (SLM) and percent body fat (PBF) were also analyzed. Results: Males with obesity had significantly higher levels of insulin, HOMA-IR, 25OHD3, ferritin, iron, hemoglobin, hematocrit, urea, and ALT compared to females (P<0.05 for all). Conversely, males had lower HDL and platelet levels (P<0.05). The prevalence of thyroid disease was significantly higher in females (P=0.027). Conclusions: Thyroid disease prevalence was significantly higher in females compared to males. Additionally, metabolic parameters such as insulin, HOMA-IR, and urea were elevated in females, while HDL and platelet levels were lower in males.

🔖

Cite This Article

Tuna, M., Kırlak, Ş., Akın, S., Madenci, Ö. Ç. (2025). Comorbidity results of an obesity center. The European Research Journal, Volume: 11 Issue: 2. https://doi.org/10.18621/eurj.1602748

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (27)

  1. Zhang X, Ha S, Lau HC, Yu J. Excess body weight: Novel insights into its roles in obesity comorbidities. Semin Cancer Biol. 2023;92:16-27. doi:10.1016/j.semcancer.2023.03.008.
  2. World Health Organisation. WHO European Regional Obesity Report 2022. 2022 [cited 2022 Nov 8]; Available from: https://apps.who.int/iris/handle/10665/353747.
  3. Nutter S, Eggerichs LA, Nagpal TS, et al. Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation. Obes Rev. 2024;25(1):e13642. doi:10.1111/obr.13642.
  4. Leung AKC, Wong AHC, Hon KL. Childhood Obesity: An Updated Review. Curr Pediatr Rev. 2024;20(1):2-26. doi:10.2174/1573396318666220801093225.
  5. TÜİK. Türkiye Sağlık Araştırması, 2019. https://data.tuik.gov.tr/Bulten/Index?p=Turkey-Health-Survey-2019-3366. Erişim tarihi 25 Ağustos, 2023.
  6. Engin A. Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction. Adv Exp Med Biol. 2024;1460:431-462. doi:10.1007/978-3-031-63657-8_15.
  7. Yazıcı D, Demir SÇ, Sezer H. Insulin Resistance, Obesity, and Lipotoxicity. Adv Exp Med Biol. 2024;1460:391-430. doi:10.1007/978-3-031-63657-8_14.
  8. Adeva-Andany MM, Domínguez-Montero A, Adeva-Contreras L, Fernández-Fernández C, Carneiro-Freire N, González-Lucán M. Body Fat Distribution Contributes to Defining the Relationship between Insulin Resistance and Obesity in Human Diseases. Curr Diabetes Rev. 2024;20(5):e160823219824. doi:10.2174/1573399820666230816111624.
  9. Kloock S, Ziegler CG, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery? Pharmacol Ther. 2023;251:108549. doi:10.1016/j.pharmthera.2023.108549.
  10. Arner P, Viguerie N, Massier L, et al. Sex differences in adipose insulin resistance are linked to obesity, lipolysis and insulin receptor substrate 1. Int J Obes (Lond). 2024;48(7):934-940. doi:10.1038/s41366-024-01501-x.
  11. Gado M, Tsaousidou E, Bornstein SR, Perakakis N. Sex-based differences in insulin resistance. J Endocrinol. 2024;261(1):e230245. doi:10.1530/JOE-23-0245.
  12. Shantaram D, Hoyd R, Blaszczak AM, et al. Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils. Nat Commun. 2024;15(1):5434. doi:10.1038/s41467-024-48935-5.
  13. Shaikh SR, Beck MA, Alwarawrah Y, MacIver NJ. Emerging mechanisms of obesity-associated immune dysfunction. Nat Rev Endocrinol. 2024;20(3):136-148. doi:10.1038/s41574-023-00932-2.
  14. Aguirre-García MM, Amedei A, Hernández-Ruiz P, et al. Cytokine and microbiota profiles in obesity-related hypertension patients. Front Cell Infect Microbiol. 2024;13:1325261. doi:10.3389/fcimb.2023.1325261.
  15. Pena-Leon V, Perez-Lois R, Villalon M, et al. Novel mechanisms involved in leptin sensitization in obesity. Biochem Pharmacol. 2024;223:116129. doi:10.1016/j.bcp.2024.116129.
  16. Chandrasekaran P, Weiskirchen R. The Role of Obesity in Type 2 Diabetes Mellitus-An Overview. Int J Mol Sci. 2024;25(3):1882. doi:10.3390/ijms25031882.
  17. Verde L, Di Lorenzo T, Savastano S, Colao A, Barrea L, Muscogiuri G. Chrononutrition in type 2 diabetes mellitus and obesity: A narrative review. Diabetes Metab Res Rev. 2024;40(2):e3778. doi:10.1002/dmrr.3778.
  18. Ragab AAY, Doyle MF, Chen J, Fang Y, Lunetta KL, Murabito JM. Immune cell phenotypes and mortality in the Framingham Heart Study. Immun Ageing. 2024;21(1):37. doi: 10.1186/s12979-024-00431-6.
  19. Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23(1):8. doi:10.1186/s12933-023-02115-9.
  20. Rempakos A, Prescott B, Mitchell GF, Vasan RS, Xanthakis V. Association of Life's Essential 8 With Cardiovascular Disease and Mortality: The Framingham Heart Study. J Am Heart Assoc. 2023;12(23):e030764. doi:10.1161/JAHA.123.030764.
  21. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88.
  22. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008;207(6):928-934.
  23. Faeh D, Braun J, Tarnutzer S, Bopp M. Obesity but not overweight is associated with increased mortality risk. Eur J Epidemiol. 2011;26(8):647-655. doi: 10.1007/s10654-011-9593-2.
  24. Chu FL, Hsu CH, Jeng C. Lowered cutoff points of obesity indicators are better predictors of hypertension and diabetes mellitus in premenopausal Taiwanese women. Obes Res Clin Pract. 2015;9(4):328-335. doi: 10.1016/j.orcp.2014.08.001.
  25. Fujita M, Hata A. Sex and age differences in the effect of obesity on incidence of hypertension in the Japanese population: A large historical cohort study. J Am Soc Hypertens. 2014;8(1):64-70. doi: 10.1016/j.jash.2013.08.001.
  26. Aoyama T, Li D, Bay JL. Weight Gain and Nutrition during Pregnancy: An Analysis of Clinical Practice Guidelines in the Asia-Pacific Region. Nutrients. 2022;14(6):1288. doi:10.3390/nu14061288.
  27. Sandalcı U, Tuncer G. [An Evaluation of Direct and Indirect Costs of Obesity]. Aksaray Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi. 2020;12(2):29-44. [Article in Turkish]